VOLORIDGE INVESTMENT MANAGEMENT, LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 277 filers reported holding CLOVIS ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.

Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2019$551,000
-18.0%
140,226
+210.4%
0.01%
-47.4%
Q2 2019$672,000
-97.0%
45,175
-81.0%
0.02%
-96.6%
Q2 2017$22,249,000
+15.4%
237,631
-21.5%
0.55%
+17.9%
Q1 2017$19,272,000
+136.2%
302,689
+64.8%
0.47%
+168.6%
Q4 2016$8,160,000
+31.3%
183,693
+171.9%
0.18%
-40.1%
Q3 2015$6,213,00067,5590.29%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q2 2017
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 150,000$1,564,0004.60%
Healthcare Value Capital, LLC 100,000$1,043,0003.07%
Palo Alto Investors LP 5,056,286$52,712,0002.90%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,328,200$13,848,0001.53%
Ikarian Capital, LLC 513,700$5,355,0000.87%
Pinz Capital Management, LP 207,800$2,166,0000.79%
Leap Investments LP 146,300$1,525,0000.72%
Elk Creek Partners, LLC 574,616$5,990,0000.69%
SECTOR GAMMA AS 408,625$4,260,0000.68%
Artal Group S.A. 1,000,000$10,425,0000.40%
View complete list of CLOVIS ONCOLOGY INC shareholders